Vertex Pharmaceuticals Advances Non-Opioid Pain Treatment Targeting Sodium Channels
Vertex Pharmaceuticals has successfully completed Phase 3 trials for suzetrigine, a novel non-opioid pain medication. By targeting specific sodium channels in the peripheral nervous system, the drug blocks pain signals…